ClinicalTrials.gg
CompletedNCT07122570Updated Aug 14, 2025

Outcomes After Total Elbow Arthroplasty

An observational study in Elbow Disease, sponsored by Wrightington, Wigan and Leigh NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-14.

Sponsored by Wrightington, Wigan and Leigh NHS Foundation Trust · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
27
Ages
18 Years and older
Sex
All
01

Study summary

This study will be an observational study involving patients from Wrightington hospital who underwent implantation of a Latitude elbow prosthesis a minimum of 2 years ago.

02

Conditions studied

  • Elbow Disease

Keywords

  • arthroplasty
03

In context

Lead sponsor

Wrightington, Wigan and Leigh NHS Foundation Trust is the lead sponsor of 7 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients who had a Latitude elbow replacement for elbow arthritis

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

All patients who have undergone primary total elbow arthroplasty at Wrightington hospital between January 2014 and June 2018 with a Latitude total elbow prosthesis

Exclusion criteria

Exclusion Criteria:

Patients who have undergone TEA with any elbow joint prosthesis other than the Latitude convertible total elbow joint prosthesis Patients whose TEA was not a primary procedure Patient not giving consent for inclusion

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
27 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Implant survival at 2 years post-surgery using a Kaplan-Meier estimate.

    standard statistical methods of Kaplan-Meier

    Time frame: survival after surgical intervention

Secondary outcomes

  1. Oxford Shoulder Score

    The Oxford Elbow Score has 12 items (questions) with 5 response options each. Each item response is scored 0 to 4, with 0 representing greater severity.

    Time frame: a single time point at 2 years or more after surgical intervention

  2. ELBEX

    a pain section, which uses three 0-10 visual analogue scale scores to record the worst pain experienced from the elbow. also contains a function section, which lists 10 activities of daily living and asks the participant to rate the level of difficulty they experience with that activity using a series of 0-10 scales)

    Time frame: a single time point at 2 years or more after surgical intervention

  3. Quick DASH

    QuickDASH only contains 11 items. It is a questionnaire that measures an individual's ability to complete tasks, absorb forces, and severity of symptoms

    Time frame: a single time point at 2 years or more after surgical intervention

  4. ASES

    divided into three sections: pain, function and satisfaction. The first section contains visual analogical scales (from 0 no pain to 10 worst pain ever) for pain evaluation. The second section contains questions relating to the function of the upper limbs

    Time frame: a single time point at 2 years or more after surgical intervention

07

Study locations

1 site
  • Wrightington, Wigan & Leigh Teaching Hospitals NHS Foundation Trust
    Wigan, WN6 9EP, United Kingdom
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2020 to primary completion in Oct 2023, 35 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 14, 2022
First posted
Aug 14, 2025
StartActual
Oct 15, 2020
Primary completionActual
Oct 1, 2023
CompletionActual
Oct 1, 2023
Last update
Aug 14, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07122570
Lead sponsor
Wrightington, Wigan and Leigh NHS Foundation Trust
Responsible party
Sponsor
First posted
Aug 14, 2025
Start date
Oct 15, 2020
Primary completion
Oct 1, 2023
Completion
Oct 1, 2023
Last update
Aug 14, 2025

Study contacts

Ian A Trail
principal investigator · Wrightington, Wigan & Leigh Teaching Hospital NHS Foundation Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion